Table 3.
Group | No. of Patients | Positive, n | L/WM (mean ± SD) | ||||
---|---|---|---|---|---|---|---|
NH3 | MET | FDG | NH3 | MET | FDG | ||
Neoplastic lesions | 67 | 42 | 63 | 24 | 2.25 ± 0.69 | 2.96 ± 0.95 | 2.00 ± 0.86 |
LGG | 27 | 6 | 24 | 1 | 1.76 ± 0.51 | 2.34 ± 0.56 | 1.36 ± 0.35 |
HGG | 30 | 27 | 30 | 18 | 2.59 ± 0.54 | 3.64 ± 0.90 | 2.59 ± 0.75 |
Non-glioma tumors | 10 | 9 | 9 | 5 | |||
NNL | 23 | 1 | 10 | 8 | 1.50 ± 0.27 | 1.88 ± 0.63 | 2.07 ± 0.71 |
LGG low-grade glioma, HGG high-grade glioma, NNL non-neoplastic lesions, L/WM Lesion-to-white matter ratio